Home | Contact | Site Map
Investor Relations - In the News
About Advantek Biologics
Research & Development
Products & Solutions
Investor Relations
Investors & Sponsors
In the News



July 2005
Purification of Human SARS Hyperimmune Globulin

22 September 2003
IDdb Reaches a Milestone — the Publishing of its 20,000th Drug Report
Thomson Current Drugs

15 September 2003
World's First SARS-Specific Investigational Drug
Asia Pacific Biotech News

April 2003
Gradipore Has Reached an Agreement with Advantek Biologics
International Blood/Plasma News, Marketing Research Bureau

May-June 2002
Swedish and HK Biotech Companies Collaborate
Hong Kong Economic and Trade Office

SARS Antiserum (Horse)

  ©2003 Advantek Biologics Limited Disclaimer